CEACAM5 and non-small cell lung carcinoma: In the Tomita et al [18] study of 291 stage I-III NSCLC patients, CEA was found to be a significant prognostic factor in patients with normal and high serum CEA levels, predicting 71.52% and 48.41% of cases, respectively (p<0.0001).